Hexosamine Pathway as a Therapeutic Strategy in Primary Mitochondrial Encephalopathy
Open Access
- 17 March 2026
- journal article
- editorial
- Published by Wiley in Acta Physiologica
- Vol. 242 (4) , e70196
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- N‐Acetylglucosamine Selectively Attenuates Neuroinflammation in a Mouse Model of Mitochondrial DysfunctionActa Physiologica, 2026
- A human brain map of mitochondrial respiratory capacity and diversityNature, 2025
- Mitochondrial dysfunction in neurodegenerative disordersNeurotherapeutics, 2023
- Understanding and exploiting the roles of O-GlcNAc in neurodegenerative diseasesJournal of Biological Chemistry, 2023
- Role ofO-linkedN-acetylglucosamine protein modification in cellular (patho)physiologyPhysiological Reviews, 2020
- The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s DiseaseMolecular Neurobiology, 2020
- Loss of O -GlcNAc glycosylation in forebrain excitatory neurons induces neurodegenerationProceedings of the National Academy of Sciences, 2016